Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice

Journal of Clinical Investigation

Volumn 117, Issue 11, 2007, Pages 3359-3368

  Sun, Jiusong ^a   Sukhova, Galina K ^a   Yang, Min ^a,b   Wolters, Paul J ^c   MacFarlane, Lindsey A ^a   Libby, Peter ^a   Sun, Chongxiu ^a   Zhang, Yadong ^a   Liu, Jian ^a   Ennis, Terri L ^d   Knispel, Rebecca ^e   Xiong, Wanfen ^e   Thompson, Robert W ^d   Baxter, B Timothy ^e   Shi, Guo Ping ^a,f  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b FIRST MILITARY MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^f Cardiovascular Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CROMOGLYCATE DISODIUM; ELASTASE; GAMMA INTERFERON; INTERLEUKIN 6; PROTEINASE;

ABDOMINAL AORTA ANEURYSM; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL ACTIVATION; CHEMICAL INJURY; CONTROLLED STUDY; DISEASE PREDISPOSITION; IMMUNOPATHOGENESIS; INFLAMMATORY DISEASE; MACROPHAGE; MALE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; AORTA; AORTIC ANEURYSM, ABDOMINAL; ELASTIN; HUMANS; INTERFERON TYPE II; INTERLEUKIN-6; MALE; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PANCREATIC ELASTASE; PROTO-ONCOGENE PROTEINS C-KIT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 36048932955     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI31311     Document Type: Article

References (56)

1. Ailawadi, G., Eliason, J.L., and Upchurch, G.R., Jr. 2003. Current concepts in the pathogenesis of abdominal aortic aneurysm. J. Vasc. Surg. 38:584-588.
2. Eliason, J.L., et al. 2005. Neutrophil depletion inhibits experimental abdominal aortic aneurysm formation. Circulation. 112:232-240.
3. Xiong, W., Zhao, Y., Prall, A., Greiner, T.C., and Baxter, B.T. 2004. Key roles of CD4+ T cells and IFN-gamma in the development of abdominal aortic aneurysms in a murine model. J. Immunol. 172:2607-2612.
4. Pyo, R., et al. 2000. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J. Clin. Invest. 105:1641-1649.
5. Longo, G.M., et al. 2002. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J. Clin. Invest. 110:625-632. doi:10.1172/JCI200215334.
6. Shimizu, K., Shichiri, M., Libby, P., Lee, R.T., and Mitchell, R.N. 2004. Th2-predominant inflammation and blockade of IFN-γ signaling induce aneurysms in allografted aortas. J. Clin. Invest. 114:300-308. doi:10.1172/JCI200419855.
7. Metzler, B., and Xu, Q. 1997. The role of mast cells in atherosclerosis. Int. Arch. Allergy Immunol. 114:10-14.
8. Ihara, M., et al. 1999. Increased chymase-dependent angiotensin II formation in human atherosclerotic aorta. Hypertension. 33:1399-1405.
9. Gurish, M.F., and Boyce, J.A. 2006. Mast cells: ontogeny, homing, and recruitment of a unique innate effector cell. J. Allergy Clin. Immunol. 117:1285-1291.
10. Li, M., et al. 2004. Involvement of chymase-mediated angiotensin II generation in blood pressure regulation. J. Clin. Invest. 114:112-120. doi:10.1172/JCI200420805.
11. Tchougounova, E., et al. 2005. A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2. J. Biol. Chem. 280:9291-9296.
12. Tsunemi, K., et al. 2004. A specific chymase inhibitor, 2-(5-formylamino-6-oxo-2-phenyl-1,6-dihydropyrimidine-1-yl)-N-[[3, 4-dioxo-1-phenyl-7-(2-pyridyloxy)]-2-heptyl]acetamide (NK3201), suppresses development of abdominal aortic aneurysm in hamsters. J. Pharmacol. Exp. Ther. 309:879-883.
13. Huang, M., Pang, X., Karalis, K., and Theoharides, T. C. 2003. Stress-induced interleukin-6 release in mice is mast cell-dependent and more pronounced in apolipoprotein E knockout mice. Cardiovasc. Res. 59:241-249.
14. Liu, J., et al. 2004. Lysosomal cysteine proteases in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 24:1359-1366.
15. Newman, K.M., Jean-Claude, J., Li, H., Ramey, W.G., and Tilson, M.D. 1994. Cytokines that activate proteolysis are increased in abdominal aortic aneurysms. Circulation. 90:II224-II227.
16. Kitamoto, S., et al. 2007. Cathepsin L deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knockout mice. Circulation. 115:2065-2075.
17. Duttlinger, R., et al. 1995. The Wsh and Ph mutations affect the c-kit expression profile: c-kit misexpression in embryogenesis impairs melanogenesis in Wsh and Ph mutant mice. Proc. Natl. Acad. Sci. U. S. A. 92:3754-3758.
18. Grimbaldeston, M.A., et al. 2005. Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am. J. Pathol. 167:835-848.
19. Sun, J., et al. 2007. Mast cells promote atherosclerosis by releasing pro-inflammatory cytokines. Nat. Med. 13:719-724.
20. Choke, E., et al. 2006. Abdominal aortic aneurysm rupture is associated with increased medial neovascularization and overexpression of proangiogenic cytokines. Arterioscler. Thromb. Vasc. Biol. 26:2077-2082.
21. Wolters, P.J., et al. 2005. Tissue-selective mast cell reconstitution and differential lung gene expression in mast cell-deficient Kit(W-sh)/Kit(W-sh) sash mice. Clin. Exp. Allergy. 35:82-88.
22. Tanzola, M.B., Robbie-Ryan, M., Gutekunst, C.A., and Brown, M.A. 2003. Mast cells exert effects outside the central nervous system to influence experimental allergic encephalomyelitis disease course. J. Immunol. 171:4385-4391.
23. Nakae, S., et al. 2005. Mast cells enhance T cell activation: importance of mast cell-derived TNF. Proc. Natl. Acad. Sci. U. S. A. 102:6467-6472.
24. Woolley, D.E. 2003. The mast cell in inflammatory arthritis. N. Engl. J. Med. 348:1709-1711.
25. Shichijo, M., et al. 1998. The effects of anti-asthma drugs on mediator release from cultured human mast cells. Clin. Exp. Allergy. 28:1228-1236.
26. Sukhova, G.K., et al. 2003. Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. J. Clin. Invest. 111:897-906. doi:10.1172/JCI200314915.
27. Lutgens, E., et al. 2006. Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation. Circulation. 113:98-107.
28. Pagano, M.B., et al. 2007. Critical role of dipeptidyl peptidase I in neutrophil recruitment during the development of experimental abdominal aortic aneurysms. Proc. Natl. Acad. Sci. U. S. A. 104:2855-2860.
29. Shi, G.P., Munger, J.S., Meara, J.P., Rich, D.H., and Chapman, H.A. 1992. Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease. J. Biol. Chem. 267:7258-7262.
30. Fang, K.C., Raymond, W.W., Lazarus, S.C., and Caughey, G.H. 1996. Dog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase. J. Clin. Invest. 97:1589-1596.
31. Miwa, K., et al. 2005. Inhibition of ets, an essential transcription factor for angiogenesis, to prevent the development of abdominal aortic aneurysm in a rat model. Gene Ther. 12:1109-1118.
32. Wang, Y.X., et al. 2005. Fasudil, a Rho-kinase inhibitor, attenuates angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice by inhibiting apoptosis and proteolysis. Circulation. 111:2219-2226.
33. Leskinen, M., Wang, Y., Leszczynski, D., Lindstedt, K.A., and Kovanen, P.T. 2001. Mast cell chymase induces apoptosis of vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 21:516-522.
34. Barath, P., et al. 1990. Tumor necrosis factor gene expression in human vascular intimal smooth muscle cells detected by in situ hybridization. Am. J. Pathol. 137:503-509.
35. Hamano, K., et al. 2003. Enhanced tumor necrosis factor-alpha expression in small sized abdominal aortic aneurysms. World J. Surg. 27:476-480.
36. Ohta, H., et al. 2005. Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice. Atherosclerosis. 180:11-17.
37. Fiane, A.E., et al. 2003. Mechanism of complement activation and its role in the inflammatory response after thoracoabdominal aortic aneurysm repair. Circulation. 108:849-856.
38. Faggioli, L., et al. 1997. Molecular mechanisms regulating induction of interleukin-6 gene transcription by interferon-gamma. Eur. J. Immunol. 27:3022-3030.
39. Biondillo, D.E., Konicek, S.A., and Iwamoto, G.K. 1994. Interferon-gamma regulation of interleukin 6 in monocytic cells. Am. J. Physiol. 267:L564-L568.
40. Jones, K.G., et al. 2001. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation. 103:2260-2265.
41. Wang, Z., et al. 2000. Interferon gamma induction of pulmonary emphysema in the adult murine lung. J. Exp. Med. 192:1587-600.
42. Leon, M.L., and Zuckerman, S.H. 2005. Gamma interferon: a central mediator in atherosclerosis. Inflamm. Res. 54:395-411.
43. Echtenacher, B., Mannel, D.N., and Hultner, L. 1996. Critical protective role of mast cells in a model of acute septic peritonitis. Nature. 381:75-77.
44. Grivennikov, S.I., et al. 2005. Distinct and nonredundant in vivo functions of TNF produced by t cells and macrophages/neutrophils: protective and deleterious effects. Immunity. 22:93-104.
45. Hiromatsu, Y., and Toda, S. 2003. Mast cells and angiogenesis. Microsc. Res. Tech. 60:64-69.
46. Paton, W.D. 1951. Compound 48/80: a potent histamine liberator. Br. J. Pharmacol. Chemother. 6:499-508.
47. Lappalainen, H., Laine, P., Pentikainen, M.O., Sajantila, A., and Kovanen, P.T. 2004. Mast cells in neovascularized human coronary plaques store and secrete basic fibroblast growth factor, a potent angiogenic mediator. Arterioscler. Thromb. Vasc. Biol. 24:1880-1885.
48. Aridor, M., Rajmilevich, G., Beaven, M.A., and Sagi-Eisenberg, R. 1993. Activation of exocytosis by the heterotrimeric G protein Gi3. Science. 262:1569-1572.
49. Colonnello, J.S., et al. 2003. Transient exposure to elastase induces mouse aortic wall smooth muscle cell production of MCP-1 and RANTES during development of experimental aortic aneurysm. J. Vasc. Surg. 38:138-146.
50. Conti, P., and DiGioacchino, M. 2001. MCP-1 and RANTES are mediators of acute and chronic inflammation. Allergy Asthma Proc. 22:133-137.
51. Hunninghake, G.W., et al. 1981. Elastin fragments attract macrophage precursors to diseased sites in pulmonary emphysema. Science. 212:925-927.
52. Stoka, V., Turk, B., and Turk, V. 2005. Lysosomal cysteine proteases: structural features and their role in apoptosis. IUBMB Life. 57:347-353.
53. Henningsson, F., Wolters, P., Chapman, H.A., Caughey, G.H., and Pejler, G. 2003. Mast cell cathepsins C and S control levels of carboxypeptidase A and the chymase, mouse mast cell protease 5. Biol. Chem. 384:1527- 1531.
54. Wolters, P.J., Pham, C.T., Muilenburg, D.J., Ley, T.J., and Caughey, G.H. 2001. Dipeptidyl peptidase I is essential for activation of mast cell chymases, but not tryptases, in mice. J. Biol. Chem. 276:18551-18556.
55. Tsai, J.C., et al. 1996. Induction of apoptosis by pyrrolidinedithiocarbamate and N-acetylcysteine in vascular smooth muscle cells. J. Biol. Chem. 271:3667-3670.
56. Galis, Z.S., Sukhova, G.K., and Libby, P. 1995. Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue. FASEB J. 9:974-980.